Post-earnings recap
Reported
Wed, Dec 22, 2010
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
25%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Arrowhead Pharmaceuticals reported an EPS of $-0.03, which met expectations, but no revenue figures were provided. Despite this, the stock rose by 10%, indicating investor optimism, possibly due to other factors not detailed in the earnings report.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.03 | N/A | +0.00% |
| Revenue | — | N/A | — |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.